CLINICAL_TRIALS
ClinicalTrials.gov record update
Intraperitoneal Aerosolization of Albumin-stabilized Paclitaxel Nanoparticles for Stomach, Pancreas, Breast and Ovarian Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03304210
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:29.413373+00:00
- Published At
- 2023-11-07T00:00:00+00:00
- Record Updated At
- 2023-11-07
- Results Posted At
- 2023-11-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Peritoneal Carcinomatosis", "Ovarian Cancer Stage IIIB", "Ovarian Cancer Stage IIIC", "Ovarian Cancer Stage IV", "Breast Cancer Stage IIIB", "Breast Cancer Stage IIIc", "Breast Cancer Stage IV", "Stomach Cancer Stage III", "Stomach Cancer Stage IV With Metastases", "Pancreas Cancer, Stage III", "Pancreas Cancer, Stage IV"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-07"- protocolSection.identificationModule.nctId
"NCT03304210"- protocolSection.identificationModule.officialTitle
"Intraperitoneal Aerosolization of Albumin-stabilized Paclitaxel Nanoparticles for Stomach, Pancreas, Breast and Ovarian Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-11-07"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.